Lemborexant
- CAS No.
- 1369764-02-2
- Chemical Name:
- Lemborexant
- Synonyms
- E 2006;CS-2189;Dayvigo.;labradon;Lemborexant;Lemborexant API;lemborexant,E2006;E-2006 Lemborexant;Lemborexant USP/EP/BP;Lemborexant Impurity 1
- CBNumber:
- CB72744022
- Molecular Formula:
- C22H20F2N4O2
- Molecular Weight:
- 410.42
- MDL Number:
- MFCD28502271
- MOL File:
- 1369764-02-2.mol
- MSDS File:
- SDS
| Melting point | 173 - 175°C |
|---|---|
| Boiling point | 596.1±50.0 °C(Predicted) |
| Density | 1.347±0.06 g/cm3(Predicted) |
| storage temp. | -20°C, Inert atmosphere |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| pka | 12.30±0.40(Predicted) |
| form | Solid |
| color | White to Off-White |
| FDA UNII | 0K5743G68X |
Lemborexant price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth Carbosynth | FL103847 | Lemborexant | 1369764-02-2 | 10mg | $245 | 2021-12-16 | Buy |
| ChemScene | CS-4320 | Lemborexant | 1369764-02-2 | 5mg | $260 | 2021-12-16 | Buy |
| AK Scientific | 1887DN | Lemborexant | 1369764-02-2 | 10mg | $380 | 2021-12-16 | Buy |
| ChemScene | CS-4320 | Lemborexant | 1369764-02-2 | 10mg | $450 | 2021-12-16 | Buy |
| ChemScene | CS-4320 | Lemborexant | 1369764-02-2 | 25mg | $800 | 2021-12-16 | Buy |
Lemborexant Chemical Properties,Uses,Production
Description
Lemborexant is a newer orexin receptor antagonist which is submitted to US FDA for review as new drug application for the treatment of insomnia after completing two key Phase 3 studies of lemborexant – SUNRISE 1 (Study 304) and SUNRISE 2 (Study 303).
Chemical Properties
Lemborexant is a white to off-white powder that is practically insoluble in water.
Uses
Lemborexant is a novel orexin receptor antagonist and is used in the treatment of insomnia, characterised by difficulties with sleep onset or sleep maintenance. Orexins are neuropeptides involved in regulating sleep and arousal by promoting wakefulness. Lemborexant blocks the binding of orexins A and B to their receptors 1 and 2 thereby reducing wakefulness and promoting sleep. Suvorexant is the other orexin receptor antagonist marketed in Australia for insomnia.
Pharmacokinetics
| Effect of food | High-fat & high-calorie meal delay Tmax & reduce Cmax |
| Tmax | 1 to 3 hours |
| Half-life | 17 hours (5 mg) and 19 hours (10 mg) |
| Metabolism | primarily metabolized by CYP3A4 |
| Excretion | Urine (29%); feces (57%) |
Drug interactions
Lemborexant is metabolized by CYP3A4 and is susceptible to interactions with medications such as amiodarone, amlodipine, carbamazepine, clarithromycin, diltiazem, fluoxetine and phenytoin. Lemborexant may affect other medications metabolised by CYP2B6, such as bupropion and methadone. Alcohol should be avoided: a single dose of alcohol can increase lemborexant concentrations up to 70%.
Mode of action
The mechanism of action of lemborexant in the treatment of insomnia is Blocks the binding of wake-promoting neuropeptides orexin A and orexin B to receptors OX1R and OX2R, presumed to suppress wake drive.
References
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf
https://www.smchealth.org/sites/main/files/file-attachments/dayvigo_for_publish.pdf?1592332002
https://www.superiorhealthplan.com/content/dam/centene/Superior/policies/pharmacy-policies/Lemborexant%20(Dayvigo)%20(CP.PMN.233)%20(PDF).pdf
Lemborexant Preparation Products And Raw materials
Lemborexant Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hebei Mojin Biotechnology Co., Ltd | +86 13288715578 +8613288715578 | sales@hbmojin.com | China | 12839 | 58 |
| Henan Bao Enluo International TradeCo.，LTD | +86-17331933971 +86-17331933971 | deasea125996@gmail.com | China | 2472 | 58 |
| BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | +86-18600796368 +86-18600796368 | sales@sjar-tech.com | China | 444 | 58 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32957 | 60 |
| Shochem(Shanghai) Co.,Ltd | 86-21-50800795 | info@shochem.com | CHINA | 288 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
| Chengdu Feibo Pharm Technology Co., Ltd | +86 028-84641798 15982321820 | abby@arkpharm.com | China | 10924 | 58 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | factory@coreychem.com | China | 29811 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6312 | 58 |
| ANHUI WITOP BIOTECH CO., LTD | +8615255079626 | eric@witopchemical.com | China | 23541 | 58 |
Related articles
- Lemborexant: A Dual Orexin Receptor Antagonist with Favorable Safety and Pharmacokinetic Profiles
- Lemborexant promotes sleep by targeting orexin receptors, with good tolerability in adults. Caution advised for respiratory is....
- Mar 29，2024
- The synthesis method of Lemborexant
- Lemborexant is an orally administered dual orexin receptor (OXR) antagonist developed by Eisai for the treatment of adults wit....
- Jan 8，2024
- Lemborexant:Pharmacodynamics,Mechanism,Side Effects
- Lemborexant is used to treat insomnia (difficulty falling asleep or staying asleep). Lemborexant belongs to a class of medicat....
- Jan 5，2023
View Lastest Price from Lemborexant manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2024-11-18 | Lemborexant
1369764-02-2
|
US $0.00 / g | 1g | More Than 99% | 100kg/Month | BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | |
 |
2023-08-02 | Lemborexant
1369764-02-2
|
US $50.00 / kg | 1kg | 99.9% | 10000MT | Henan Bao Enluo International TradeCo.，LTD | |
 |
2023-07-05 | Lemborexant
1369764-02-2
|
US $0.00 / KG | 1KG | 99% | 50000KG/month | Hebei Mojin Biotechnology Co., Ltd |
-
- Lemborexant
1369764-02-2
- US $0.00 / g
- More Than 99%
- BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
-
- Lemborexant
1369764-02-2
- US $50.00 / kg
- 99.9%
- Henan Bao Enluo International TradeCo.，LTD
-
- Lemborexant
1369764-02-2
- US $0.00 / KG
- 99%
- Hebei Mojin Biotechnology Co., Ltd